Parkman Healthcare Partners LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001777015

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2026 · 90 positions · Total reported value $1.11B · Top-10 concentration 32.5% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 68.0% · 26 new · 31 cut · 13 exited

Active Share (vs S&P 500): 97.4% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.8% · vs SPY -4.9% · Prev Value $976.83M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.8% · vs SPY -4.0% · Latest Value $1.11B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Parkman Healthcare Partners LLC disclosed 90 equity positions with a combined reported value of $1.11B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 32.5% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were PTCT ($45.37M), LLY ($44.11M), MBX ($42.00M). By sector, the heaviest allocations are Health Care 95.2%, Consumer Staples 2.2%. Versus the prior quarter, allocation shifted toward Health Care (+3.1pp) and away from Industrials (-1.8pp), Consumer Staples (-1.9pp).

Versus the prior quarter, Parkman Healthcare Partners LLC opened 26 new positions, trimmed 31 and fully exited 13, a turnover rate of 68.0% of positions. The portfolio's overlap with the prior quarter was 62% of names.

The largest new positions opened in Q3 2026 were SRRK ($26.09M), CRL ($17.70M), KOD ($17.63M).

Of the 13 positions fully exited versus the prior quarter, the largest were SYK ($21.40M), ZBH ($20.02M), BCRX ($16.24M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • SRRK SCHOLAR ROCK HLDG CORP · $26.09M
  • CRL CHARLES RIV LABS INTL INC · $17.70M
  • KOD KODIAK SCIENCES INC · $17.63M
  • ABT ABBOTT LABORATORIES · $16.33M
  • WST WEST PHARMACEUTICAL SVSC INC · $14.83M
  • ATRC ATRICURE INC · $12.66M
  • INSM INSMED INC · $11.99M
  • SDGR SCHRODINGER INC · $11.64M

Fully Exited (vs previous quarter)

  • SYK STRYKER CORPORATION · prev qtr: $21.40M
  • ZBH ZIMMER BIOMET HOLDINGS INC · prev qtr: $20.02M
  • BCRX BIOCRYST PHARMACEUTICALS INC · prev qtr: $16.24M
  • QURE UNIQURE NV · prev qtr: $9.59M
  • AMRX AMNEAL PHARMACEUTICALS INC · prev qtr: $9.37M
  • BSX BOSTON SCIENTIFIC CORP · prev qtr: $7.70M
  • RMD RESMED INC · prev qtr: $6.43M
  • ALGN ALIGN TECHNOLOGY INC · prev qtr: $6.23M

Insider Transactions (Form 4)

Latest Parkman Healthcare Partners LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Parkman Healthcare Partners LLC, based in Stamford, CT, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 90 positions worth $1.11B in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: STAMFORD, CT, United States
  • SEC registration: 801-114849 (status: Approved), registered 2019-03-15
  • Regulatory AUM (Form ADV): $1.74B as of 2026-03-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds

Portfolio Structure

  • 90 positions · $1.11B reported value (Q3 2026)
  • Top 10 holdings = 32.5% of reported value
  • Largest position: PTCT (PTC THERAPEUTICS INC) at 4.1%
  • Average position size: $12.31M

Sector Tilt

  • Health Care 95.2%
  • Consumer Staples 2.2%
  • Industrials 1.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 26 new, 31 added, 31 reduced, 13 exited
  • 2 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund is actively increasing exposure to biotech/therapeutics (PTCT, IQV, INBX, VRDN, URGN, SRRK) while trimming larger-cap healthcare (MBX, DXCM) and consumer staples (CVS), suggesting a bullish stance on innovative healthcare and a preference for growth-oriented names. 2. Key moves: - Added: PTCT (+60.8% shares), IQV (+37.2%), INBX (+40.2%), VRDN (+21.6%), URGN (+331.0%), SRRK (new). - Reduced: MBX (-10.5%), DXCM (-18.3%), CVS (-26.9%), LLY (-8.9% shares). 3. Portfolio structure: Active, concentrated (top 10 = 29.2%), heavily biased toward Health Care (90%), with high risk appetite (small/mid-cap biotech focus). 4. Per-holding one-liner: - PTCT: Biotech (gene therapies) - LLY: Big Pharma (diabetes/oncology) - MBX: Biotech (cancer therapeutics) - IQV: Healthcare data/analytics - DXCM: Medical devices (diabetes monitoring) - INBX: Biotech (cancer therapeutics) - VRDN: Biotech (thyroid disease) - URGN: Biotech (urology) - SRRK: Biotech (muscle disorders) - CVS: Consumer Staples (pharmacy/retail) 5. Style summary: Aggressive biotech tilt with selective cuts in large-cap healthcare and consumer staples.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 04:41

Sector Allocation

Health Care 95.2%
Technology 0.8%
Other 0.2%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 700.39K $45.37M 4.09%
4.09%
Add
2 38.12K $44.11M 3.98%
3.98%
Add
3 716.54K $42.00M 3.79%
3.79%
Reduce
4 145.22K $39.04M 3.52%
3.52%
Add
5 437.03K $37.71M 3.40%
3.40%
Reduce
6 360.26K $36.05M 3.25%
3.25%
Add
7 1.67M $34.48M 3.11%
3.11%
Add
8 750.20K $30.48M 2.75%
2.75%
Add
9 540.00K $26.09M 2.35%
2.35%
New
10 286.29K $24.53M 2.21%
2.21%
Reduce
11 948.86K $24.22M 2.19%
2.19%
Add
12 633.31K $21.06M 1.90%
1.90%
Reduce
13 1.11M $20.78M 1.88%
1.88%
Add
14 55.87K $20.51M 1.85%
1.85%
Hold
15 675.10K $19.65M 1.77%
1.77%
Add
16 796.26K $18.70M 1.69%
1.69%
Add
17 521.58K $18.70M 1.69%
1.69%
Add
18 60.00K $17.70M 1.60%
1.60%
New
19 186.00K $17.63M 1.59%
1.59%
New
20 675.52K $17.45M 1.57%
1.57%
Reduce
21 600.05K $17.34M 1.56%
1.56%
Add
22 213.40K $16.77M 1.51%
1.51%
Add
23 165.18K $16.33M 1.47%
1.47%
New
24 63.85K $16.32M 1.47%
1.47%
Reduce
25 1.64M $15.70M 1.42%
1.42%
Reduce
26 195.56K $14.96M 1.35%
1.35%
Reduce
27 40.00K $14.83M 1.34%
1.34%
New
28 929.43K $14.25M 1.29%
1.29%
Add
29 1.13M $13.98M 1.26%
1.26%
Add
30 726.86K $13.74M 1.24%
1.24%
Add
31 185.85K $13.50M 1.22%
1.22%
Reduce
32 327.95K $13.31M 1.20%
1.20%
Reduce
33 367.91K $13.07M 1.18%
1.18%
Add
34 200.41K $13.03M 1.18%
1.18%
Reduce
35 225.25K $12.66M 1.14%
1.14%
New
36 27.88K $12.25M 1.11%
1.11%
Reduce
37 105.06K $11.99M 1.08%
1.08%
New
38 678.57K $11.81M 1.07%
1.07%
Add
39 375.00K $11.64M 1.05%
1.05%
New
40 50.07K $11.59M 1.05%
1.05%
New
41 772.18K $11.05M 1.00%
1.00%
Reduce
42 779.76K $10.97M 0.99%
0.99%
Add
43 329.25K $10.15M 0.92%
0.92%
Add
44 85.74K $9.75M 0.88%
0.88%
Add
45 130.00K $9.02M 0.81%
0.81%
New
46 110.00K $9.01M 0.81%
0.81%
New
47 425.35K $8.98M 0.81%
0.81%
New
48 283.76K $8.87M 0.80%
0.80%
Reduce
49 275.83K $8.83M 0.80%
0.80%
Add
50 35.16K $8.68M 0.78%
0.78%
Reduce

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 60% R 60% F1 60% (modelled on 2026-Q2; 6/10 hit)

Low-confidence forecast This fund replaces about 40% of its Top-10 each quarter and backtests at F1 59% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (11 quarters)

Avg precision 59% · recall 59% · F1 59% · avg rank error 3.5 · Top-10 turnover 40%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 70% 70% 70% BSX · UTHR · THC · COO · DXCM · INSP · RXST · PODD · COR · NBIX THC · UTHR · BSX · COO · SDGR · LLY · DXCM · COR · RXST · SNDX
2024-Q2 70% 70% 70% COO · THC · SDGR · UTHR · BSX · LLY · COR · DXCM · RXST · SNDX BSX · PODD · UTHR · LLY · COO · THC · AGIO · LBPH · RXST · DXCM
2024-Q3 50% 50% 50% BSX · PODD · UTHR · COO · LLY · LBPH · AGIO · THC · ELV · DXCM BSX · PODD · LLY · COO · KROS · TFX · UTHR · MNKD · KNSA · VRNA
2024-Q4 60% 60% 60% PODD · BSX · LLY · COO · KROS · TFX · MNKD · UTHR · ITCI · KNSA GILD · VRNA · PODD · BSX · SYK · COO · LLY · VRDN · ITCI · MNKD
2025-Q1 60% 60% 60% GILD · VRNA · SYK · PODD · BSX · COO · VRDN · RCUS · LLY · ITCI PODD · CVS · LLY · SYK · THC · BDX · COO · UNH · GILD · BSX
2025-Q2 60% 60% 60% CVS · PODD · LLY · SYK · THC · BDX · UNH · GILD · COO · ZBH CVS · PODD · BSX · ALNY · THC · COO · LLY · QGEN · ZBH · DHR
2025-Q3 60% 60% 60% CVS · ALNY · PODD · THC · BSX · COO · LLY · QGEN · ZBH · DHR QQQ · BSX · ALNY · PODD · CVS · KNSA · VRDN · ZBH · SYK · QGEN
2025-Q4 50% 50% 50% QQQ · BSX · ALNY · PODD · CVS · KNSA · ZBH · VRDN · KALV · DHR BSX · PODD · DXCM · SYK · CVS · MCK · KALV · MBX · KNSA · MASI
2026-Q1 60% 60% 60% BSX · DXCM · PODD · SYK · CVS · MCK · KALV · KNSA · LIVN · MBX SYK · DXCM · KALV · PODD · LLY · PTCT · XENE · BSX · CVS · RCUS
2026-Q2 50% 50% 50% SYK · DXCM · KALV · LLY · PODD · PTCT · XENE · RCUS · BSX · CVS MBX · LLY · CVS · DXCM · PTCT · RCUS · GPCR · VRDN · AGIO · INBX
2026-Q3 ★ 60% 60% 60% LLY · MBX · CVS · PTCT · DXCM · GPCR · VRDN · RCUS · AGIO · XENE PTCT · LLY · MBX · IQV · DXCM · INBX · VRDN · URGN · SRRK · CVS

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-16. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-16 Trading days33 Holdings16 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-16, and will update as prices arrive.

Portfolio return+2.63%Buy & hold
QQQ synthetic benchmark-17.01%Liquidity weighted
Excess return+19.65%vs benchmark
Barra annualised vol20.4%Model estimate
Realised vol19.8%Annualised in window
Weighted beta0.70Raw exposure
Factor / specific risk67% / 33%Share of variance
Top-10 concentration83.0%Of reported value
Portfolio value (start = 100)78.285.692.9100.3107.710-0110-2311-16Parkman Healthcare Partners LLCQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)+2.63%Disclosed long book
QQQ synthetic benchmark-17.01%Liquidity-weighted constituents
Model universe, equal weight-1.70%Opportunity-cost reference
Excess return+19.65%Portfolio − benchmark
Arithmetic return sum+2.85%Difference vs compounded is the cross term
Weighted raw beta0.70Weighted holding betas
Realised volatility (annualised)19.78%Daily returns in window
Barra model volatility (annualised)20.39%Factor + specific
Factor share of variance67.0%Barra factors
Specific share of variance33.0%Stock residuals
Reported value$301.6M13F long US equity

2. Return attribution

The +2.85% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 +1.42% 50.0%
Momentum & Growth 3 -0.50% -17.5%
Volatility & Tail Risk 7 +3.80% 133.4%
Industry 12 +6.82% 239.7%
Specific 1 -8.70% -305.6%
Return attribution (style + industry, %)-6.4-3.2+0.0+3.2+6.4Growth+0.49Non-linear Size+0.56Leverage (Downside Vol)+0.71Size+0.74Beta-0.74Historical Volatility-0.95Momentum-0.98Consumer Staples+1.04Mid Cap-1.11Turnover+1.42Residual Volatility+2.67Skewness-2.83Kurtosis+4.58Health Care+5.92
Factor Type Exposure Factor return Contribution Share of |return|
Health Care Industry +0.85 +6.98% +5.92% 208.2%
Kurtosis Style +0.61 +7.51% +4.58% 160.8%
Residual Volatility Style +0.81 +3.29% +2.67% 93.7%
Turnover Style -0.30 -4.80% +1.42% 50.0%
Consumer Staples Industry +0.08 +12.82% +1.04% 36.6%
Size Style -0.38 -1.95% +0.74% 26.0%
Leverage (Downside Vol) Style -0.42 -1.71% +0.71% 25.1%
Non-linear Size Style +0.56 +1.01% +0.56% 19.8%
Growth Style +0.28 +1.75% +0.49% 17.3%
Max Drawdown Style -0.20 -1.76% +0.36% 12.5%
Information Technology Industry +0.03 -5.13% -0.15% -5.4%
Amihud Illiquidity Style +0.51 -0.45% -0.23% -8.0%
Beta Style -0.17 +4.44% -0.74% -26.2%
Historical Volatility Style +0.07 -14.00% -0.95% -33.2%
Momentum Style +0.24 -4.00% -0.98% -34.3%
Mid Cap Style +0.58 -1.94% -1.11% -39.2%
Skewness Style +0.64 -4.39% -2.83% -99.3%
Specific Specific — — -8.70% -305.6%

3. Risk attribution

Annualised volatility is 20.39%; factor risk explains 67.0% of variance and specific risk 33.0%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-53.0-26.5+0.0+26.5+53.0Beta-1.95Skewness-0.55Growth+0.57Information Technology+0.75Industrials+1.32Kurtosis+1.80Max Drawdown+1.83Momentum+2.22Leverage (Downside Vol)+2.61Size+2.68Consumer Staples+3.12Mid Cap+3.29Specific+32.95Health Care+49.10
Factor Type Exposure Share of variance Vol contribution Share of vol
Health Care Industry +0.85 49.1% +10.01% 10.0%
Specific Specific — 33.0% +6.72% 6.7%
Mid Cap Style +0.58 3.3% +0.67% 0.7%
Consumer Staples Industry +0.08 3.1% +0.64% 0.6%
Size Style -0.38 2.7% +0.55% 0.6%
Leverage (Downside Vol) Style -0.42 2.6% +0.53% 0.5%
Momentum Style +0.24 2.2% +0.45% 0.5%
Max Drawdown Style -0.20 1.8% +0.37% 0.4%
Kurtosis Style +0.61 1.8% +0.37% 0.4%
Industrials Industry +0.04 1.3% +0.27% 0.3%
Information Technology Industry +0.03 0.8% +0.15% 0.1%
Growth Style +0.28 0.6% +0.12% 0.1%
Residual Volatility Style +0.81 -0.3% -0.06% -0.1%
Skewness Style +0.64 -0.6% -0.11% -0.1%
Beta Style -0.17 -1.9% -0.40% -0.4%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-0.9-0.10.71.62.4Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -0.38 +2.10 -2.48
Non-linear Size +0.56 +1.68 -1.12
Mid Cap +0.58 +0.13 +0.45
Beta -0.17 +1.29 -1.46
Momentum +0.24 +0.72 -0.47
Short-term Reversal -0.01 -0.64 +0.63
Residual Volatility +0.81 -0.40 +1.21
Historical Volatility +0.07 +0.86 -0.79
Liquidity +0.10 +0.11 -0.01
Amihud Illiquidity +0.51 +1.16 -0.65
Turnover -0.30 +0.21 -0.50
Growth +0.28 +0.58 -0.30
Leverage (Downside Vol) -0.42 +0.14 -0.56
Skewness +0.64 +0.24 +0.41
Kurtosis +0.61 +0.21 +0.40
Max Drawdown -0.20 -0.08 -0.12

5. Industry allocation & Brinson

Industry allocation (weight, %)-8.517.042.467.993.3Communication ServicesUtilitiesConsumer DiscretionaryInformation TechnologyIndustrialsConsumer StaplesHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 3.0% 73.6% -20.93% -22.33% +3.67% +1.03% -0.99% +15.82%
Health Care 84.8% 1.7% +3.32% +8.29% +21.12% -0.09% -4.12% +2.68%
Communication Services 0.0% 2.6% +0.00% -17.64% +0.01% +0.46% -0.46% +0.46%
Consumer Staples 8.1% 0.8% +3.38% +15.26% +2.36% -0.10% -0.87% +0.15%
Utilities 0.0% 0.8% +0.00% +11.13% -0.22% -0.09% +0.09% -0.09%
Consumer Discretionary 0.0% 8.8% +0.00% +3.76% -1.84% -0.33% +0.33% -0.33%
Industrials 4.1% 11.1% +3.19% +4.36% -1.51% -0.13% +0.08% -0.35%
Total +23.48% +0.73% -5.91% +18.30%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
LLY ELI LILLY & CO Health Care 14.62% +23.73% +3.47% Add
IQV IQVIA HLDGS INC Health Care 12.95% -1.53% -0.20% Add
DXCM DEXCOM INC Health Care 12.50% -5.42% -0.68% Reduce
SRRK SCHOLAR ROCK HLDG CORP Health Care 8.65% -7.82% -0.68% New
CVS CVS HEALTH CORP Consumer Staples 8.13% +3.38% +0.27% Reduce
UNH UNITEDHEALTH GROUP INC Health Care 6.80% +12.24% +0.83% Hold
ABT ABBOTT LABORATORIES Health Care 5.41% +8.72% +0.47% New
LIVN LIVANOVA PLC Health Care 4.96% +20.84% +1.03% Reduce
WST WEST PHARMACEUTICAL SVSC INC Health Care 4.92% +12.69% +0.62% New
WAT WATERS CORP Industrials 4.06% +3.19% +0.13% Reduce
INSM INSMED INC Health Care 3.98% +7.66% +0.30% New
SDGR SCHRODINGER INC Health Care 3.86% -11.88% -0.46% New
TEM TEMPUS AI INC Information Technology 2.99% -20.93% -0.62% New
GPCR STRUCTURE THERAPEUTICS INC Health Care 2.94% -40.61% -1.20% Reduce
ALNY ALNYLAM PHARMACEUTICALS INC Health Care 2.88% -35.26% -1.01% Reduce
LQDA LIQUIDIA CORPORATION Health Care 0.35% +86.29% +0.30% New
Contribution rank Symbol Sector Weight Return Contribution
1 LLY Health Care 14.62% +23.73% +3.47%
2 LIVN Health Care 4.96% +20.84% +1.03%
3 UNH Health Care 6.80% +12.24% +0.83%
4 WST Health Care 4.92% +12.69% +0.62%
5 ABT Health Care 5.41% +8.72% +0.47%
6 INSM Health Care 3.98% +7.66% +0.30%
7 LQDA Health Care 0.35% +86.29% +0.30%
8 CVS Consumer Staples 8.13% +3.38% +0.27%
9 TEM Information Technology 2.99% -20.93% -0.62%
10 SRRK Health Care 8.65% -7.82% -0.68%
11 DXCM Health Care 12.50% -5.42% -0.68%
12 ALNY Health Care 2.88% -35.26% -1.01%
13 GPCR Health Care 2.94% -40.61% -1.20%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-16 (33 trading days), the reported portfolio returned +2.63%, versus -17.01% for the QQQ synthetic benchmark — an excess of +19.65%.
  2. Return attribution: the largest positive style/industry contributions came from Health Care +5.92%, Kurtosis +4.58%, Residual Volatility +2.67%; the largest drags came from Skewness -2.83%, Mid Cap -1.11%, Momentum -0.98%. Specific (stock-level) return contributed -8.70%.
  3. Risk attribution: Barra model volatility is 20.39% annualised; factor risk explains 67% of variance and specific risk 33%. The largest factor risk sources are Health Care 49.1%, Mid Cap 3.3%, Consumer Staples 3.1%.
  4. Style tilt: size -0.38, momentum +0.24, volatility +0.07, liquidity +0.10; the weighted raw beta is 0.70. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+83.1 pp), the largest underweight is Information Technology (-70.6 pp). Allocation contributed +23.48%, selection +0.73% and interaction -5.91%.
  6. Concentration: the top-10 positions are 83.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did Parkman Healthcare Partners LLC buy in 2026-Q3?

In its 2026-Q3 13F filing, Parkman Healthcare Partners LLC reported 90 equity positions worth $1.11B in aggregate; its largest disclosed positions were PTCT ($45.37M), LLY ($44.11M), MBX ($42.00M).

How large is Parkman Healthcare Partners LLC's portfolio?

Parkman Healthcare Partners LLC reported $1.11B of long equity holdings across 90 positions as of 2026-Q3. Top-10 holdings account for 32.5% of reported value.

What is Parkman Healthcare Partners LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/parkman-healthcare-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →